Loading insider details...
Beta
Latest Form 4 (Sep 14, 2026): Exercise/Conversion of 50,000 RYTM shares, $302.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 50,000 | $302.5K |
| Jun 22, 2026 | Kardigan, Inc. (KARD) | Grant/Award | 20,706 | n/a |
| Jun 4, 2026 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 35,000 | n/a |
| Feb 13, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/Award | 71,900 | n/a |
| Feb 3, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 68,713 | n/a |
| Jun 13, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 45,000 | n/a |
| Jun 5, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 43,620 | $200.2K |
| Feb 20, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 21,250 | n/a |
| Feb 5, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 14,125 | n/a |
| Aug 29, 2024 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 4,555 | $6.5K |